The past couple of days have felt like a waking nightmare for many of us. Sure, any presidential election is bound to bring ...

Author Media Contact For general and media inquiries and to book our experts, please contact: [email protected] Background A ...

Substance abuse and behavioral disorder counselors provide treatment and support for those struggling with an addiction to drugs or alcohol, or for those burdened by an eating disorder or a ...

How Much Does a Substance Abuse and Behavioral Disorder Counselor Make? Substance Abuse and Behavioral Disorder Counselors made a median salary of $49,710 in 2022. The best-paid 25% made $64,400 ...

In an effort to address the growing opioid addiction crisis in Ontario, a group of Ontario-based health workers, pharmaceutical experts, first responders, non-profits, union leaders, and big city ...

The human amygdala (pictured in orange) plays an important role in addiction. Researchers at the Center for Genetics, Genomics, and Epigenetics of Substance Use Disorders in Outbred Rats study genes ...

Sleep Apnea Contributes to Dementia in Older Adults, Especially Women Oct. 31, 2024 — Sleep apnea, a common yet underdiagnosed sleep disorder ... Regular Mobile Phone Use May Increase the ...

La version française suitAn updated evidence-based guideline aimed at helping clinicians and other health care providers manage patients with opioid ...

Nov. 6, 2024 — A new study has challenged the perception heavy social media use has a significant impact on mental health, finding little to no relationship between the two. In fact, not only ...

Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.

FMR1-dependent cellular phenotype compatible with high throughput drug screening.